Regenerx Biopharma buy melinda
Start price
01.11.10
/
50%
€0.13
Target price
02.05.11
€0.20
Performance (%)
-17.32%
End price
02.05.11
€0.11
Summary
This prediction ended on 02.05.11 with a price of €0.11. The price of Regenerx Biopharma has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.32%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Regenerx Biopharma | - | - | - | - |
| iShares Core DAX® | 1.776% | 3.175% | 14.882% | 17.660% |
| iShares Nasdaq 100 | -1.037% | 1.869% | 35.463% | 52.324% |
| iShares Nikkei 225® | -0.335% | 3.857% | 14.485% | 11.459% |
| iShares S&P 500 | 0.854% | 2.567% | 31.105% | 47.441% |
Comments by melinda for this prediction
In the thread Regenerx Biopharma diskutieren
Biopharma-
regernerx Biopharma hat die Rechte der NIH, dass das Unternehmen seine Aufmerksamkeit auf ProtectOn und die Reparatur von Gewebe konzentrieren können erworben
(Laufzeit überschritten)